# Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation

> **NCT03500848** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Southern Medical University, China** · enrollment: 130 (estimated)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Tacrolimus (Tacrolimus elimination)
- **DRUG:** Sirolimus
- **DRUG:** MMF and/or steroids

## Key facts

- **NCT ID:** NCT03500848
- **Lead sponsor:** Southern Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03500848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03500848, "Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03500848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*